top of page
Elio Health seeks to invest in companies across the healthcare continuum that enable their customers to deliver superior products or services for patients, caregivers and providers.
About Us
Elio Health was founded by George Fotiades and Seth Yellin in 2022. George and Seth worked together for a decade as the key leadership at Cantel Medical, a leader in infection prevention products and services that served hospitals, ambulatory sites, dental practices and dialysis clinics. At Cantel, they led commercial, operational, organizational, financial and strategic initiatives, including 28 acquisitions, to accelerate growth, drive global expansion and enhance its competitive position in key markets. Their success culminated in the sale of Cantel to Steris Corporation for $4.6 billion in 2021. In addition to Cantel, they bring proven executive and board experience across a range of high-profile public and private health care businesses including Cardinal Health, Catalent, Aptar and Curia. Today, backed by financial sponsor support and significant personal commitment, they seek investment opportunities in a variety of areas across the healthcare continuum, including pharmaceutical services, life science tools, medical devices as well as supply chain technology and product providers.
Why The Name Elio?
Elio is derived from the Greek word “Helios”, the sun, which generates light and life-giving energy through fusion. Elio Health was formed to partner with businesses, leaders and investors to energize performance through strategic focus, commercial execution and operational efficiency. With deep experience in strengthening organizational processes, developing customer solutions and executing strategic acquisitions, Elio Health strives to generate better outcomes for patients, caregivers and providers.
WHO WE ARE
bottom of page